Clinical Evidence

Delve into clinical research studies and more 

Clinical research lies at the heart of who we are. Vantive uses scientific evidence systematically and transparently, to inform the development of state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Vantive.

254 results

HDx therapy enabled by Theranova
Efficacy and safety of expanded hemodialysis in hemodialysis patients: a meta-analysis and systematic review
Visit resource site
HDx therapy enabled by Theranova
Efficacy and Safety of Expanded Hemodialysis with the Theranova 400 Dialyzer: A Randomized Controlled Trial
Visit resource site
HDx therapy enabled by Theranova
Efficacy of enoxaparin in preventing coagulation during high-flux haemodialysis, expanded haemodialysis and haemodiafiltration
Visit resource site
HDx therapy enabled by Theranova
Efficacy of expanded hemodialysis at different dialysate flows
Visit resource site
HDx therapy enabled by Theranova
Efficacy of Medium Cut-Off Dialyzer and Comparison with Standard High-Flux Hemodialysis
Visit resource site
HDx therapy enabled by Theranova
Efficacy of medium cut-off dialyzers and comparison with high-flux dialyzers in patients on maintenance hemodialysis: A systematic review and meta-analysis
Visit resource site
HDx therapy enabled by Theranova
End-Stage Renal Disease, Inflammation and Cardiovascular Outcomes
Visit resource site
HDx therapy enabled by Theranova
Endotoxin Retentive Performance of the Fresenius FX CorAL Dialyzer.
Visit resource site
HDx therapy enabled by Theranova
Evaluating a remote patient monitoring program for automated peritoneal dialysis - Ariza J, et al.
Visit resource site
HDx therapy enabled by Theranova
Evaluation and comparison of polysulfone TS-UL and PMMA NF-U dialyzers versus expanded hemodialysis and postdilution hemodiafiltration.
Visit resource site
HDx therapy enabled by Theranova
Evaluation of Albumin Loss During Hemodialysis with Theranova® Medium Cut-Off (MCO) Dialyzer: Six Months Follow-Up
Visit resource site
HDx therapy enabled by Theranova
Evaluation of the efficacy of a medium cut-off dialyser and comparison with other high-flux dialysers in conventional haemodialysis and online haemodiafiltration
Visit resource site

Vantive is a trademark of Vantive Health LLC or its affiliates.